# GAGE12F

## Overview
GAGE12F is a gene that encodes the G antigen 12F protein, which is part of the GAGE family of cancer/testis antigens. These proteins are typically expressed in a restricted manner, predominantly in the testis and various cancer cells, making them of particular interest in oncology research. The G antigen 12F protein is involved in several cellular processes related to tumorigenesis and cancer progression. It is categorized as a cancer/testis antigen, which is a class of proteins that are considered potential targets for cancer immunotherapy due to their limited expression in normal tissues and elevated presence in tumors (Kalvapudi2024Cancertestis). The gene's expression and the protein's interactions have been linked to clinical outcomes in multiple cancer types, suggesting its utility as a prognostic marker and a candidate for targeted cancer therapies (Broyl2010Gene; Arias2023Electrostatic).

## Clinical Significance
GAGE12F, a member of the GAGE family of cancer/testis antigens, is implicated in various malignancies due to its altered expression levels. In multiple myeloma, the presence of GAGE12F correlates with significantly shorter event-free survival, indicating its potential role in disease progression (Broyl2010Gene). In glioblastoma, higher electrostatic complementarity scores between T-cell receptors and GAGE12F are associated with worse disease-free survival probabilities, suggesting a negative impact on patient outcomes (Arias2023Electrostatic).

In gastroesophageal adenocarcinoma, GAGE12F is part of a cluster of cancer/testis antigens that show higher expression levels, which are linked to survival outcomes, particularly in patients treated with immune checkpoint inhibitors (Kalvapudi2024Cancertestis). Additionally, in gastric cancer with bone metastasis, GAGE12F is identified as a hub node in a protein-protein interaction network, highlighting its potential importance in the biological interactions among differentially expressed genes (Oh2024Genomic).

These findings suggest that GAGE12F may serve as a prognostic marker and a potential target for therapeutic interventions in various cancers, given its association with poor survival outcomes and its role in cancer progression.


## References


[1. (Kalvapudi2024Cancertestis) Sukumar Kalvapudi, Akhil Goud Pachimatla, R. J. Seager, Jeffrey Conroy, Sarabjot Pabla, and Sarbajit Mukherjee. Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma. Medical Oncology, August 2024. URL: http://dx.doi.org/10.1007/s12032-024-02475-6, doi:10.1007/s12032-024-02475-6. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12032-024-02475-6)

[2. (Oh2024Genomic) Sujin Oh, Soo Kyung Nam, Keun-Wook Lee, Hye Seung Lee, Yujun Park, Yoonjin Kwak, Kyu Sang Lee, Ji-Won Kim, Jin Won Kim, Minsu Kang, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, and Hyung Ho Kim. Genomic and transcriptomic characterization of gastric cancer with bone metastasis. Cancer Research and Treatment, 56(1):219–237, January 2024. URL: http://dx.doi.org/10.4143/crt.2023.340, doi:10.4143/crt.2023.340. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.4143/crt.2023.340)

[3. (Broyl2010Gene) Annemiek Broyl, Dirk Hose, Henk Lokhorst, Yvonne de Knegt, Justine Peeters, Anna Jauch, Uta Bertsch, Arjan Buijs, Marian Stevens-Kroef, H. Berna Beverloo, Edo Vellenga, Sonja Zweegman, Marie-Josée Kersten, Bronno van der Holt, Laila el Jarari, George Mulligan, Hartmut Goldschmidt, Mark van Duin, and Pieter Sonneveld. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood, 116(14):2543–2553, October 2010. URL: http://dx.doi.org/10.1182/blood-2009-12-261032, doi:10.1182/blood-2009-12-261032. This article has 251 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2009-12-261032)

[4. (Arias2023Electrostatic) Miguel A. Arias, Konrad J. Cios, Dorottya B. Kacsoh, Bailey E. Montgomery, Joanna J. Song, Anishaa R. Patel, Andrea Chobrutskiy, Boris I. Chobrutskiy, and George Blanck. Electrostatic complementarities of glioblastoma-resident t-cell receptors and cancer testis antigens linked to poor outcomes and high levels of sphingosine kinase-2 expression. Biology, 12(4):575, April 2023. URL: http://dx.doi.org/10.3390/biology12040575, doi:10.3390/biology12040575. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biology12040575)